
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Latest articles from ONA Pancreatic Cancer</title>
        <link>http://www.oncologynurseadvisor.com</link>
        <description>Latest articles from ONA Pancreatic Cancer</description>
        <itunes:author>ONA</itunes:author>
        <itunes:subtitle>Pancreatic Cancer</itunes:subtitle>
        <itunes:summary>Pancreatic cancer news and feature articles for oncology nurses.</itunes:summary>
        <itunes:owner>
            <itunes:name>Pancreatic Cancer</itunes:name>
            <itunes:email>Admin@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.oncologynurseadvisor.com/images/2010/06/01/onalogo-mobile_103794.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>New metabolite-based diagnostic test could help detect pancreatic cancer early</title>
          <description>A new diagnostic test that uses the technique of metabolomic analysis may be a safe and easy screening method that could improve the prognosis of patients with pancreatic cancer through earlier detection.</description>
          <link>http://www.oncologynurseadvisor.com/new-metabolite-based-diagnostic-test-could-help-detect-pancreatic-cancer-early/article/289478/</link>
          <pubDate>Thu, 18 Apr 2013 22:00:00 GMT</pubDate>
          <itunes:summary>A new diagnostic test that uses the technique of metabolomic analysis may be a safe and easy screening method that could improve the prognosis of patients with pancreatic cancer through earlier detection.</itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
        <item>
          <title>Drug combination extends survival of patients with pancreatic cancer</title>
          <description>A multicenter phase III clinical trial has demonstrated that nab-paclitaxel (Abraxane) plus gemcitabine extends the survival of late-stage pancreatic cancer patients compared with standard treatment.</description>
          <link>http://www.oncologynurseadvisor.com/drug-combination-extends-survival-of-patients-with-pancreatic-cancer/article/279003/</link>
          <pubDate>Tue, 05 Feb 2013 14:00:00 GMT</pubDate>
          <itunes:summary>A multicenter phase III clinical trial has demonstrated that nab-paclitaxel (Abraxane) plus gemcitabine extends the survival of late-stage pancreatic cancer patients compared with standard treatment.</itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
        <item>
          <title>New drug combination improved overall survival in advanced pancreatic cancer</title>
          <description>Overall survival was significantly improved in patients with late-stage pancreatic cancer who received a new combination of cancer drugs compared with those who received standard treatment.</description>
          <link>http://www.oncologynurseadvisor.com/new-drug-combination-improved-overall-survival-in-advanced-pancreatic-cancer/article/271051/</link>
          <pubDate>Tue, 04 Dec 2012 20:00:00 GMT</pubDate>
          <itunes:summary>Overall survival was significantly improved in patients with late-stage pancreatic cancer who received a new combination of cancer drugs compared with those who received standard treatment.</itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
        <item>
          <title>Cloud data on cancer may lead to more effective treatments</title>
          <description>Cloud technology is now being used to collect detailed information from thousands of cancer samples with the goal of helping doctors make better predictions about how a patient&apos;s illness will progress and what type of treatment will be most effective.</description>
          <link>http://www.oncologynurseadvisor.com/cloud-data-on-cancer-may-lead-to-more-effective-treatments/article/269144/</link>
          <pubDate>Tue, 20 Nov 2012 20:00:00 GMT</pubDate>
          <itunes:summary>Cloud technology is now being used to collect detailed information from thousands of cancer samples with the goal of helping doctors make better predictions about how a patient&apos;s illness will progress and what type of treatment will be most effective.</itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
        <item>
          <title>Deviations from radiation protocols increase the risk of treatment failure and death</title>
          <description>When measures are implemented to ensure that radiation protocols are followed, deviations decrease and overall survival improves in patients with cancer.</description>
          <link>http://www.oncologynurseadvisor.com/deviations-from-radiation-protocols-increase-the-risk-of-treatment-failure-and-death/article/266663/</link>
          <pubDate>Mon, 05 Nov 2012 14:00:00 GMT</pubDate>
          <itunes:summary>When measures are implemented to ensure that radiation protocols are followed, deviations decrease and overall survival improves in patients with cancer.</itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
        <item>
          <title>Diabetes from pancreas removal may be manageable side effect</title>
          <description>Patients who undergo total pancreatectomy due to cancer or precancerous cysts in the pancreas may be able to achieve glycemic control.</description>
          <link>http://www.oncologynurseadvisor.com/diabetes-from-pancreas-removal-may-be-manageable-side-effect/article/259865/</link>
          <pubDate>Fri, 21 Sep 2012 11:00:00 GMT</pubDate>
          <itunes:summary>Patients who undergo total pancreatectomy due to cancer or precancerous cysts in the pancreas may be able to achieve glycemic control.</itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
        <item>
          <title>Quantity/quality of life in pancreatic cancer examined</title>
          <description>Knowing how much time people with pancreatic cancer spend in the hospital or in medical care can help clinicians make treatment recommendations.</description>
          <link>http://www.oncologynurseadvisor.com/quantityquality-of-life-in-pancreatic-cancer-examined/article/258953/</link>
          <pubDate>Fri, 14 Sep 2012 11:00:00 GMT</pubDate>
          <itunes:summary>Knowing how much time people with pancreatic cancer spend in the hospital or in medical care can help clinicians make treatment recommendations.</itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
        <item>
          <title>&quot;Inoperable&quot; pancreatic cancer may be treatable after all</title>
          <description>Oncologists at M.D. Anderson Cancer Center found the key to screening for pancreatic cancer lies in the interpretation of preoperative CT scans.</description>
          <link>http://www.oncologynurseadvisor.com/inoperable-pancreatic-cancer-may-be-treatable-after-all/article/255023/</link>
          <pubDate>Wed, 15 Aug 2012 04:00:00 GMT</pubDate>
          <itunes:summary>Oncologists at M.D. Anderson Cancer Center found the key to screening for pancreatic cancer lies in the interpretation of preoperative CT scans.</itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
        <item>
          <title>Chemotherapy can help after periampullary cancer resection</title>
          <description>Adjuvant chemotherapy administered after surgery for cancers near the pancreas confers a modest but statistically significant survival benefit.</description>
          <link>http://www.oncologynurseadvisor.com/chemotherapy-can-help-after-periampullary-cancer-resection/article/253014/</link>
          <pubDate>Thu, 02 Aug 2012 11:00:00 GMT</pubDate>
          <itunes:summary>Adjuvant chemotherapy administered after surgery for cancers near the pancreas confers a modest but statistically significant survival benefit.</itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
        <item>
          <title>Scientists expose deadly trick behind pancreatic cancer </title>
          <description>Pancreatic tumor cells create an immunosuppressive environment in which they can divide freely, a discovery that could improve treatment.</description>
          <link>http://www.oncologynurseadvisor.com/scientists-expose-deadly-trick-behind-pancreatic-cancer/article/246833/</link>
          <pubDate>Thu, 28 Jun 2012 11:00:00 GMT</pubDate>
          <itunes:summary>Pancreatic tumor cells create an immunosuppressive environment in which they can divide freely, a discovery that could improve treatment.</itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
        <item>
          <title>Clinical Trial: Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery</title>
          <description>A look at the following clinical trial: Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery</description>
          <link>http://www.oncologynurseadvisor.com/clinical-trial-vaccine-therapy-with-or-without-cyclophosphamide-in-treating-patients-undergoing-chemotherapy-and-radiation-therapy-for-stage-i-or-stage-ii-pancreatic-cancer-that-can-be-removed-by-surgery/article/207586/</link>
          <pubDate>Thu, 14 Jul 2011 20:52:38 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery</itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
        <item>
          <title>Clinical Trial: Early Increase in Blood Flow (EIBS) in the Duodenum in Patients With Pancreatic Cancer</title>
          <description>A look at the following clinical trial: Early Increase in Blood Flow (EIBS) in the Duodenum in Patients With Pancreatic Cancer</description>
          <link>http://www.oncologynurseadvisor.com/clinical-trial-early-increase-in-blood-flow-eibs-in-the-duodenum-in-patients-with-pancreatic-cancer/article/207583/</link>
          <pubDate>Thu, 14 Jul 2011 20:51:02 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Early Increase in Blood Flow (EIBS) in the Duodenum in Patients With Pancreatic Cancer</itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
        <item>
          <title>Clinical Trial: Stool Testing for Pancreatic Cancer</title>
          <description>A look at the following clinical trial: Stool Testing for Pancreatic Cancer</description>
          <link>http://www.oncologynurseadvisor.com/clinical-trial-stool-testing-for-pancreatic-cancer/article/207582/</link>
          <pubDate>Thu, 14 Jul 2011 20:49:16 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Stool Testing for Pancreatic Cancer</itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
        <item>
          <title>Clinical Trial: Computer Tools for Improving Early Diagnosis and Treatment in Healthy Volunteers or Patients With Pancreatic Cancer or Who Are At Risk For Pancreatic Cancer or Who Have a Noncancer Pancreatic Disorder</title>
          <description>A look at the following clinical trial: Computer Tools for Improving Early Diagnosis and Treatment in Healthy Volunteers or Patients With Pancreatic Cancer or Who Are At Risk For Pancreatic Cancer or Who Have a Noncancer Pancreatic Disorder</description>
          <link>http://www.oncologynurseadvisor.com/clinical-trial-computer-tools-for-improving-early-diagnosis-and-treatment-in-healthy-volunteers-or-patients-with-pancreatic-cancer-or-who-are-at-risk-for-pancreatic-cancer-or-who-have-a-noncancer-pancreatic-disorder/article/207579/</link>
          <pubDate>Thu, 14 Jul 2011 20:45:35 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Computer Tools for Improving Early Diagnosis and Treatment in Healthy Volunteers or Patients With Pancreatic Cancer or Who Are At Risk For Pancreatic Cancer or Who Have a Noncancer Pancreatic Disorder</itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
        <item>
          <title>Clinical Trial: A Pilot Study, Evaluating the Efficacy of Regulatory T-cell Suppression by Ontak in Metastatic Pancreatic Cancer</title>
          <description>A look at the following clinical trial: A Pilot Study, Evaluating the Efficacy of Regulatory T-cell Suppression by Ontak in Metastatic Pancreatic Cancer</description>
          <link>http://www.oncologynurseadvisor.com/clinical-trial-a-pilot-study-evaluating-the-efficacy-of-regulatory-t-cell-suppression-by-ontak-in-metastatic-pancreatic-cancer/article/175990/</link>
          <pubDate>Fri, 30 Jul 2010 15:20:26 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: A Pilot Study, Evaluating the Efficacy of Regulatory T-cell Suppression by Ontak in Metastatic Pancreatic Cancer</itunes:summary>
          <itunes:author>ONA</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  